RNA viruses pose significant challenges to public health due to their high mutation rates and diverse mechanisms of infection which allow them to rapidly adapt to new hosts and evade therapeutic ...
Antiviral drug development is now progressing at the pace antibiotics were 30 years ago. At present, there are some 60 antiviral drug preparations that have been approved by the US FDA ...
Four antiviral drugs are available for the prevention and treatment of influenza infections: oseltamivir, zanamivir, rimantadine and amantadine. Oseltamivir and zanamivir are neuraminidase ...